52w high/low | ₹313.45 / ₹156 |
P/E ratio | 344.83 |
Dividend | 0.14 |
ROE | 2.08 |
ROCE | 3.47 |
Face value | 10 |
Book value | ₹120.24Cr |
Market capital | ₹54,409.83Cr |
What is shareholding pattern? Who are shareholders?
What is a cash flow statement?
What is a balance sheet?
What is a profit and loss statement?
What are dividends?
What are bonuses?
Fortis Healthcare Limited (FHL) is amongst the leading healthcare delivery chains in the country currently encompassing both hospitals and diagnostics businesses. It operates a network of 34 hospitals across the country and internationally with a bed capacity of more than 4,600 which catered to more than 2. 6 million patients in FY17. These hospitals include multi-specialty hospitals as well as super-specialty centers providing tertiary and quaternary healthcare to patients in areas such as cardiac care, orthopedics, neurosciences, oncology, renal care, gastroenterology and mother and child care. They are delivering quality healthcare services to patients in modern facilities using advanced technology. Fortis Healthcare also has presence in Dubai, Mauritius and Sri Lanka SRL Limited, a subsidiary of FHL is primarily involved in providing diagnostics services and is amongst the leading diagnostics chains in India with a significant market share in the organized diagnostics segment. It had a network of 356 laboratories and 5,245 collection points as of FY17. FHL currently owns a fully diluted stake of 56.